Important Safety Information: Certain patients should not use CERDELGA based on their CYP2D6 metabolizer status due to an increased risk of side effects, including heart problems. Do not use CERDELGA if you are an Extensive Metabolizer (EM) taking a medicine that is a strong or moderate CYP2D6 inhibitor along with another medicine that is a strong or... View more

We Choose Cerdelga

Cerdelga® (eliglustat) capsule

It's Your Turn

Cerdelga is the ONLY first-line oral therapy indicated for the long-term treatment of most adults with Gaucher disease type 1

Learn more about starting treatment
or switching to Cerdelga »

CERDELGA is a prescription medicine used for the long-term treatment of Gaucher disease type 1 (GD1) in adults who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test. Your doctor will perform a test to make sure that CERDELGA is right for you.

Limitations of Use: CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA to achieve a therapeutic effect. A specific dose cannot be recommended for CYP2D6 indeterminate metabolizers.

Talk to your doctor about starting or
switching to Cerdelga

Is Cerdelga right for you? Is Cerdelga right for you?
Learn about starting treatment

Get started
Your disease is progressive Your disease is progressive
Early and ongoing treatment is important

Learn more
Your disease is progressive Staying on Track
Education and support for Cerdelga patients

View resources